Marek Mráz Research Group
Address: | Kamenice 753/5, 625 00 Brno, Building E35 |
---|
Phone: | +420 549 49 8143 |
---|---|
E-mail: |
Total number of publications: 5
Articles
-
Blockage of BCL-XL overcomes venetoclax resistance across BCL2-positive lymphoid malignancies irrespective of BIM status
Blood advances, year: 2024, volume: 8, edition: 13, DOI
-
Computational Design of Pore-Forming Peptides with Potent Antimicrobial and Anticancer Activities
Journal of Medicinal Chemistry, year: 2024, volume: 67, edition: 16, DOI
-
FoxO1 signaling in B cell malignancies and its therapeutic targeting.
FEBS Letters, year: 2024, DOI
-
FoxO1/Rictor axis induces a non-genetic adaptation to Ibrutinib via Akt activation in chronic lymphocytic leukemia
The Journal of Clinical Investigation, year: 2024, DOI
-
Stromal cells engineered to express T cell factors induce robust CLL cell proliferation in vitro and in PDX co-transplantations allowing the identification of RAF inhibitors as anti-proliferative drug
Leukemia, year: 2024, volume: 38, edition: 8, DOI